Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.

Article  Google Scholar 

Giordano C, La Camera G, Gelsomino L, Barone I, Bonofiglio D, Andò S, Catalano S. The biology of exosomes in breast cancer progression: dissemination, immune evasion and metastatic colonization. Cancers. 2020;12(8):2179.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta P, Neupane YR, Parvez S, Kohli K. Recent advances in targeted nanotherapeutic approaches for breast cancer management. Nanomedicine. 2021;16(29):2605–31.

Article  CAS  PubMed  Google Scholar 

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P et al. Breast cancer (primer) Nat. Rev Dis Primers. 2019;66.

Cheang MC, Martin M, Nielsen TO, Prat A, Voduc D, Rodriguez-Lescure A, et al. Defining breast cancer intrinsic subtypes by quantitative receptor expression. Oncologist. 2015;20(5):474–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong GL, Abu Jalboush S, Lo H-W. Exosomal MicroRNAs and organotropism in breast cancer metastasis. Cancers. 2020;12(7):1827.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amens JN, Bahçecioglu G, Zorlutuna P. Immune System effects on breast Cancer. Cell Mol Bioeng. 2021;14(4):279–92.

Article  PubMed  PubMed Central  Google Scholar 

Emens LA. Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade. Expert Rev Anticancer Ther. 2012;12(12):1597–611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006;90:1–50.

CAS  PubMed  Google Scholar 

Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3(11):991–8.

Article  CAS  PubMed  Google Scholar 

Emens LA. Breast Cancer Immunotherapy: facts and HopesBreast Cancer Immunotherapy. Clin Cancer Res. 2018;24(3):511–20.

Article  CAS  PubMed  Google Scholar 

Edechi CA, Ikeogu N, Uzonna JE, Myal Y. Regulation of immunity in breast cancer. Cancers. 2019;11(8):1080.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329–60.

Article  CAS  PubMed  Google Scholar 

Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater. 2020;32(51):2002440.

Article  CAS  Google Scholar 

Hussen BM, Abdullah KH, Abdullah SR, Majeed NM, Mohamadtahr S, Rasul MF, et al. New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets. Noncoding RNA Res. 2023;8(4):645–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, He D, Wan K, Sheng X, Cheng H, Huang J, et al. In situ multiplex detection of serum exosomal microRNAs using an all-in-one biosensor for breast cancer diagnosis. Analyst. 2020;145(9):3289–96.

Article  CAS  PubMed  Google Scholar 

Yi Y, Wu M, Zeng H, Hu W, Zhao C, Xiong M, et al. Tumor-derived exosomal non-coding RNAs: the emerging mechanisms and potential clinical applications in breast Cancer. Front Oncol. 2021;11:738945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Q, Wang J, Zhang H, Sun L, Liu J, Meng L, Li J. Tumor-derived exosomes RNA expression profiling identifies the prognosis, immune characteristics, and treatment in HR+/HER2-breast cancer. Aging. 2023;15(16):8471–86.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Shi J, Liu W, Zhang K, Zhao H, Zhang H, Zhang Z. A simple, specific and on-off type MUC1 fluorescence aptasensor based on exosomes for detection of breast cancer. Sens Actuators B. 2018;276:552–9.

Article  CAS  Google Scholar 

Kennedy LB, Salama AK. A review of cancer immunotherapy toxicity. Cancer J Clin. 2020;70(2):86–104.

Article  Google Scholar 

Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19(1):1–16.

Article  Google Scholar 

Lipson EJ, Forde PM, Hammers H-J, Emens LA, Taube JM, Topalian SL, editors. Antagonists of PD-1 and PD-L1 in cancer treatment. Seminars in oncology. Elsevier; 2015.

Emens LA, Ascierto PA, Darcy PK, Demaria S, Eggermont AM, Redmond WL, et al. Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape. Eur J Cancer. 2017;81:116–29.

Article  CAS  PubMed  Google Scholar 

Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–93.

Article  PubMed  Google Scholar 

Pitt JM, Charrier M, Viaud S, André F, Besse B, Chaput N, Zitvogel L. Dendritic cell–derived exosomes as immunotherapies in the fight against cancer. J Immunol. 2014;193(3):1006–11.

Article  CAS  PubMed  Google Scholar 

Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79.

Article  PubMed  Google Scholar 

Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–32.

Article  CAS  PubMed  Google Scholar 

Kalluri R. The biology and function of exosomes in cancer. J Clin Investig. 2016;126(4):1208–15.

Article  PubMed  PubMed Central  Google Scholar 

Aslan C, Maralbashi S, Salari F, Kahroba H, Sigaroodi F, Kazemi T, Kharaziha P. Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol. 2019;234(10):16885–903.

Article  CAS  PubMed  Google Scholar 

Tran T-H, Mattheolabakis G, Aldawsari H, Amiji M. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. Clin Immunol. 2015;160(1):46–58.

Article  CAS  PubMed  Google Scholar 

Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H. Skvortsova I-I. therapy resistance mediated by exosomes. Mol Cancer. 2019;18(1):1–11.

Article  Google Scholar 

Pu X, Ma S, Gao Y, Xu T, Chang P, Dong L. Mesenchymal stem cell-derived exosomes: biological function and their therapeutic potential in radiation damage. Cells. 2020;10(1):42.

Article  PubMed  PubMed Central  Google Scholar 

Klinke DJ, Kulkarni YM, Wu Y, Byrne-Hoffman C. Inferring alterations in cell‐to‐cell communication in HER2 + breast cancer using secretome profiling of three cell models. Biotechnol Bioeng. 2014;111(9):1853–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab‐based therapy. J Cell Physiol. 2012;227(2):658–67.

Article  CAS  PubMed  Google Scholar 

Maas SL, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–88.

Article  CAS  PubMed  Google Scholar 

Johnstone RM, Adam M, Hammond J, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412–20.

Article  CAS  PubMed  Google Scholar 

Ni Z, Zhou S, Li S, Kuang L, Chen H, Luo X, et al. Exosomes: roles and therapeutic potential in osteoarthritis. Bone Res. 2020;8(1):1–18.

Article  Google Scholar 

Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocols cell Biology. 2006;30(1):3. 1–3. 9.

Article  Google Scholar 

Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, et al. Exosomes as Emerging Drug Delivery and Diagnostic modality for breast Cancer: recent advances in isolation and appli